With over ten years of experience caring for children and adolescents with cancer, Dr. Nader Kim El-Mallawany’s clinical niche is rooted in lymphomas/lymphoproliferative disorders, HIV-related malignancies (particularly Kaposi sarcoma), and the treatment of childhood cancer in low-income countries.
Dr. El-Mallawany is a member of the Lymphoma and Histiocytosis Teams at the Texas Children’s Cancer and Hematology Center with special interests in mature B-cell non-Hodgkin lymphomas (NHL), Epstein-Barr virus-associated lymphomas/lymphoproliferative disorders, as well as the rare NHL of childhood and adolescence. Over the years, his clinical research in lymphoma has focused on the role of viruses in the pathogenesis of lymphomas, as well as the development of chemoimmunotherapy protocols for mature B-cell non-Hodgkin lymphomas.
He is also a member of the Global HOPE (Hematology-Oncology Pediatric Excellence) program, having spent four years working at the Baylor International Pediatric AIDS Initiative (BIPAI) Clinical Centre of Excellence and Kamuzu Central Hospital (KCH) in Malawi’s capital city, Lilongwe. During his time there, he pioneered the establishment of a comprehensive pediatric hematology/oncology treatment and care program at KCH, the referral hospital that serves nearly half of Malawi’s population of 15 million people. He also developed one of the world’s largest pediatric HIV-related malignancy programs at the BIPAI clinic, which has cared for over 200 children and adolescents with Kaposi sarcoma (KS) over the past decade.
He is board certified by the American Board of Pediatrics in both pediatrics and pediatric hematology-oncology.